Loading...
Loading...
SNOA| Name | Value |
|---|---|
| Revenues | 3,014.0K |
| Cost of Revenue | 2,150.0K |
| Gross Profit | 864.0K |
| Operating Expense | 2,011.0K |
| Operating I/L | -1,147.0K |
| Other Income/Expense | -292.0K |
| Interest Income | 12.0K |
| Pretax | -1,439.0K |
| Income Tax Expense | -131.0K |
| Net Income/Loss | -1,308.0K |
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions globally. Its product line includes antimicrobial facial cleansers, prescription products for dermatoses management, scar treatment gels, solutions for seborrhea and seborrheic dermatitis, eye care products, oral care solutions, wound healing products, animal health solutions, and hospital-grade disinfectants. The company generates revenue by selling these HOCl-based products to healthcare providers, veterinarians, and consumers for various medical and cosmetic applications.
